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Introduction: As there is no reliable criterion for early di-
agnosis of preeclampsia up to present date, this study was 
conducted to compare the serum levels of thyroid-stim-
ulating hormone in preeclampsia and non-preeclampsia 
pregnant women and the use of thyroid-stimulating hor-
mone (TSH) as a predictive factor in preeclampsia.
Method: In this case-control study, 45 non-preeclampsia 
pregnant women and 45 preeclampsia pregnant women 
in the third trimester of pregnancy referred to Kamali Hos-
pital of Karaj were examined. A skilled person took 10 cc 
of venous blood of the subjects and the mean serum TSH 
levels of both groups were compared by using SPSS, ver-
sion 22, software.
Results: The mean serum TSH level was 2.55 ± 1.13 and 
3.08 ± 1.23, respectively, in non-preeclampsia pregnant 
women and preeclampsia pregnant women, the relation-
ship was statistically significant (P =0.013). Besides, the 
prevalence of preterm delivery in preeclampsia pregnant 
women was higher than that in non-preeclampsia preg-
nant women (P = .000). The mean weight of neonates 
in preeclampsia pregnant women was lower than that in 
non- preeclampsia pregnant women (P = .000).
Conclusion: This study revealed that measuring serum 
TSH levels in the third trimester of pregnancy could be a 
predictor of preeclampsia.
Keywords: Thyroid-stimulating hormone, Pregnant 
women, Preeclampsia.
Resumen: introducción: Como no existe un criterio segu-
ro para el diagnóstico precoz de preeclampsia hasta la fe-
cha, este estudio se realizó con el objetivo de comparar los 
niveles séricos de hormona estimulante de la tiroides en 
mujeres embarazadas con preeclampsia y sin preeclamp-
sia y el uso de este medicamente. La hormona estimulante 
(TSH) como factor predicativo en la preeclampsia. 
Método: en este estudio de casos y controles, se exami-
naron mujeres embarazadas sin preeclampsia y mujeres 
embarazadas con preeclampsia en el tercer trimestre del 
embarazo derivadas al Hospital Kamali de Karaj. Un ex-
perto tomó 10 cc de sangre venosa de los sujetos y se 
compararon los niveles medios de TSH sérica de ambos 
grupos utilizando el software SPSS, versión 22.
Resultados: el nivel medio de TSH en suero fue de 2.55 
± 1.13 y 3.08 ±1.23, respectivamente, en mujeres emba-
razadas sin preeclampsia y en mujeres embarazadas con 
preeclampsia, la relación fue estadísticamente significativa 
(p= 0.013). Además, la prevalencia del parto prematuro 
en mujeres embarazadas con preeclampsia fue mayor que 
en mujeres embarazadas sin preeclampsia (p=.000). El 
peso medio de los neonatos en mujeres embarazadas con 
preeclampsia fue menor que en mujeres embarazadas sin 
preeclampsia. (P=.000)
Conclusión: Este estudio demostró que la medición del 
nivel sérico de TSH en el tercer trimestre del embarazo 
podría ser un predictor de preeclamsia. 
Palabras clave: hormona estimulante de la tiroides, mu-
jeres embarazadas, preeclampsia
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reeclampsia has particular importance since 
it is considered as one of the causes of ma-
ternal and fetal mortality and it is the main 
cause of hospitalization and preterm delivery1. Early diag-
nosis of preeclampsia is one of the most important func-
tions of prenatal care. With early diagnosis of this disease, 
maternal and fetal mortality rate decreases2. No definitive 
method has yet been proven to diagnose this disease, and 
there is still no reliable criterion for early diagnosis of pre-
eclampsia. There are several clinical, biophysical and bio-
chemical tests to identify women at risk for preeclampsia. 
The results of recent studies suggested the negligible pre-
dictive value of them in early diagnosis of preeclampsia3. A 
few studies have been conducted on the level of thyroid-
stimulating hormone and preeclampsia, but it is predicted 
that there is a correlation between preeclampsia and thy-
roid function4. Given what was stated above, this study 
was conducted to compare the serum levels of thyroid-
stimulating hormone in preeclampsia and non-preeclamp-
sia pregnant women and the use of thyroid-stimulating 
hormone as a predictive factor in preeclampsia.
his study was a case-control study. Convenience 
sampling method was used in this study and 
the sample size was measured based on com-
paring two means using the G power 3.1.2 software. Ac-
cording to α =0.05 (first type error), β =0.2 (second type 
error) and d =0.6 (effect size), 90 pregnant women in the 
third trimester of pregnancy referred to Kamali Hospital of 
Karaj were selected. According to the scientific criteria in 
the obstetrics and gynecology references, they were divid-
ed into two groups of 45 preeclampsia pregnant women 
and non-preeclampsia pregnant women (each group in-
cluded 45 women). Diagnosis of the patient group was 
performed by a gynecologist based on the following crite-
ria: pressure greater than or equal to 140 / 90 mmHg (two 
times at time interval of at least 6 hours), protein excretion 
in urine more than or equal to + 1 in a random sample of 
urine and the presence of non-gravity dependent edema. 
The control group included healthy pregnant women who 
referred to one of the obstetric clinics for follow-up dur-
ing pregnancy and had none of the signs and symptoms 
of pregnancy toxicity. The research exclusion criteria in-
cluded the occurrence of any of hypothyroidism diseases, 
Graves, autoimmune thyroiditis, chronic blood pressure, 
thyroid nodule toxicity, kidney diseases, use of drugs af-
fecting the thyroid function such as levothyroxine and 
anti-thyroid drugs, blood pressure-lowering drugs, blood 
sugar-lowering drugs, corticosteroids, diuretics and other 
drugs, such as amiodarone and lithium. In this study, 10 
ml of venous blood was taken from each patient (control 
or patient) before delivery and serum TSH level was mea-
sured in both groups. Data were also collected through 
biographies, clinical examination, completion of the 
questionnaire and recording of the results of laboratory 
tests. The questionnaire contained personal and medical 
history including pregnancy status and signs and symp-
toms of preeclampsia.
Finally, the collected data were analyzed using SPSS, ver-
sion 22, software and Student T-test. For more statistical 
tests, Chi-square, T-test and Mann-Whitney tests were 
used. P-values  less than 5% were considered significant. 
The results were presented as mean ± standard deviation 
and number (percent).
n this study, 45 healthy pregnant women without 
preeclampsia and 45 pregnant women with pre-
eclampsia referring to the obstetric department 
of Kamali Hospital in Karaj were examined according to 
inclusion criteria from March to September 2018. The 
mean age of non- preeclampsia pregnant women was 
29.2±0.61 and the mean age of preeclampsia pregnant 
women were 28.1±5.7 years, which did not show a sig-
nificant difference (P=0.76). The mean gestational age in 
healthy women (non-preeclampsia pregnant women) was 
39±1.32 weeks and mean gestational age in preeclamp-
sia pregnant women was 37±1.95 weeks (P=0.85). Out 
of 45 pregnant women with preeclampsia, 33 cases 
(73.3%) had mild preeclampsia and 12 cases (26.7%) 
had severe preeclampsia.
The mean systolic blood pressure was 121±7.44 in non-
preeclampsia pregnant women and it was 149.7±7.28 in 
preeclampsia pregnant women. The mean diastolic blood 
pressure was 75.00±7.69 in non-preeclampsia pregnant 
women and it was 90.00 ±11.94 in preeclampsia preg-
nant women. The mean serum TSH level was 2.55± 1.13 
in non-preeclampsia pregnant women and 3.08±1.23 in 
preeclampsia pregnant women (P=0.013) (Table 1).
Table 1. The mean serum TSH level in both groups of non-
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According to the results, out of 45 non-preeclampsia 
pregnant women, 35 (77.8%) had a normal delivery and 
10 (22.2%) had a cesarean delivery. Besides, out of 45 
preeclampsia pregnant women, 26 (57.8%) had a normal 
delivery and 19 (42.2%) had cesarean delivery (P=0.07) 
(Table 2). Based on Table 2, the Chi-square test also showed 
a significant relationship between preeclampsia and 
preterm delivery (P=000), while no significant relationship 
was found between preeclampsia and IUFD (P=0.500) and 
gender of neonates (P=0.522). Besides, based on Table 2, 
Independent T-test showed that there was a significant 
relationship between birth weight and preeclampsia 
(P=000). According to the Mann-Whitney test, there was 
a significant relationship between preeclampsia and first 
minute Apgar (P=0.003).
Table 2. Results of pregnancy-gender, preterm delivery, and 
intrauterine death (IUFD), preterm delivery, and first minute 









male 24 (53.3 %) 28 (62.2 %) 0.522
Preterm delivery
N (%) 2 (4.4 %) 22 (48.9 %) 0.000
IUFD
N(%) 0 (0 %) 1 (1.1 %) 0.500
First minute Apgar
Mean±SD 36.0 ± 84.9 56.1 ± 28.9 0.003
Birth weight (g)
Mean±SD 23.466 ± 3230 25.656 ± 2700 0.000
Caesarean delivery 
N(%) 10 (22.2 %) 19 (42.2 %) 0.07
n the present study, a significant difference was 
found between the mean serum TSH level in the 
two groups of preeclampsia and non-preeclampsia 
pregnant women, which strongly supported the hypoth-
esis that thyroid dysfunctions could be one of the causes 
of preeclampsia. As a result, measuring serum TSH level in 
the third trimester of pregnancy could predict preeclamp-
sia to reduce maternal and fetal complications. However, 
due to the small sample size, further studies are need-
ed to confirm this hypothesis. In a study conducted by 
Kharb et al., the mean TSH in non-preeclampsia pregnant 
women was less than that of pregnant women with se-
vere preeclampsia and the mean weight of neonates of 
preeclampsia women was less than the mean weight of 
neonates of non-preeclampsia women5. In the present 
study, the mean weight of neonates of preeclampsia preg-
nant women was lower than the mean weight of neo-
nates of non-preeclampsia women. However, in the study 
conducted by Naghshineh et al, there was no significant 
relationship between neonatal weight and hypothyroid-
ism and preeclampsia6.
dditionally, the results showed that the 
prevalence of preterm delivery in pre-
eclampsia pregnant women was dif-
ferent from that in non-preeclampsia pregnant women7. In 
a study conducted by Swati et al., the results also showed 
that the mean serum TSH level in preeclampsia pregnant 
women was higher than the mean serum TSH level in non-
preeclampsia pregnant women8. In a study conducted by 
Sardana et al, it was concluded that the mean serum TSH 
level in both preeclampsia pregnant women and non- pre-
eclampsia pregnant women was higher than the mean se-
rum TSH level in non-pregnant women9-10. 
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